What is the recommended treatment for acne vulgaris?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 3, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment for Acne Vulgaris

Start all acne patients on adapalene 0.1–0.3% gel combined with benzoyl peroxide 2.5–5% applied once nightly as the foundation, then escalate based on severity by adding oral doxycycline 100 mg daily for moderate-to-severe inflammatory acne, always with concurrent benzoyl peroxide to prevent resistance. 1

Assessment and Severity Classification

  • Use the Physician Global Assessment (PGA) to consistently classify acne as mild, moderate, or severe based on lesion counts and distribution 1, 2
  • Evaluate for scarring, post-inflammatory hyperpigmentation, and psychosocial impact—the presence of any of these factors warrants more aggressive treatment regardless of lesion count 1, 2
  • Look specifically for premenstrual flares and jaw-line distribution in females, which indicate hormonal acne requiring hormonal therapy 1

Severity-Based Treatment Algorithm

Mild Acne (Predominantly Comedonal)

  • First-line: Topical retinoid (adapalene 0.1–0.3% preferred) + benzoyl peroxide 2.5–5% applied once nightly 1, 2
  • Adapalene is preferred because it can be applied simultaneously with benzoyl peroxide without oxidation concerns, lacks photolability restrictions, and is available over-the-counter 1
  • Apply after washing and allowing skin to dry for 20–30 minutes, using a pea-sized amount for each facial area (forehead, chin, each cheek) 1
  • Alternative for post-inflammatory hyperpigmentation: Add azelaic acid 15–20%, which is particularly useful for patients with darker skin tones 1, 3

Moderate Acne (Mixed Comedonal and Inflammatory)

  • First-line: Fixed-dose combination of topical retinoid + benzoyl peroxide 1, 2
  • Add for inflammatory lesions: Topical antibiotic (clindamycin 1% or erythromycin 3%) combined with benzoyl peroxide—never as monotherapy due to rapid resistance development 1, 2
  • Fixed-combination products (clindamycin 1%/benzoyl peroxide 5% or 3.75%) enhance compliance and are applied once daily in the evening 1
  • For adult females with inflammatory acne: Consider topical dapsone 5% gel, which is particularly effective in this population and requires no G6PD testing 1

Moderate-to-Severe Inflammatory Acne

  • First-line triple therapy: Oral doxycycline 100 mg once daily + topical retinoid + benzoyl peroxide 1, 2
  • Doxycycline is strongly recommended with moderate-certainty evidence as the first-line oral antibiotic 1, 2
  • Second-line oral antibiotic: Minocycline 100 mg once daily if doxycycline is not tolerated 1, 2
  • Critical: Limit systemic antibiotics to 3–4 months maximum to minimize bacterial resistance, then transition to maintenance with topical retinoid alone 1, 2
  • Always combine oral antibiotics with benzoyl peroxide—never use antibiotics as monotherapy 1, 2
  • Counsel patients on doxycycline: Avoid tanning beds and sun lamps throughout therapy to prevent severe phototoxic reactions 1

Severe Nodular or Recalcitrant Acne

  • Isotretinoin is indicated for: (1) severe nodular acne, (2) moderate acne resistant after 3–4 months of appropriate therapy, (3) any acne with scarring or significant psychosocial burden 1, 4
  • Standard dosing: 0.5–1.0 mg/kg/day targeting cumulative dose of 120–150 mg/kg 1
  • Monitoring: Obtain baseline liver function tests and lipid panel; repeat at 2 months—routine CBC monitoring is not required in healthy patients 1
  • Population-based studies have not identified increased risk of neuropsychiatric conditions or inflammatory bowel disease with isotretinoin 1
  • Mandatory: Pregnancy prevention through iPledge program for all persons of childbearing potential 1, 5
  • Adjunctive therapy for large painful nodules: Intralesional triamcinolone acetonide 2.5–10 mg/mL provides rapid pain relief and inflammation reduction within 48–72 hours 1, 4

Hormonal Therapy for Female Patients

Spironolactone

  • Indications: Premenstrual flares, jaw-line acne, moderate-to-severe inflammatory acne unresponsive to topical therapy, or patients who cannot tolerate or prefer to avoid oral antibiotics 1, 2
  • Dosing: Start 50 mg daily, titrate to 100 mg daily as needed (up to 200 mg daily for hirsutism or hair loss) 1
  • No potassium monitoring needed in healthy patients without renal disease or concurrent potassium-affecting medications 1
  • Expect improvement after 3 months, with maximal benefit at 6 months 1
  • Must be combined with reliable contraception due to teratogenic potential 1

Combined Oral Contraceptives (COCs)

  • FDA-approved formulations containing norgestimate, norethindrone, or drospirenone reduce inflammatory lesions by 62% at 6 months 1, 3
  • Can be used as monotherapy or combined with topical agents 1
  • Drospirenone-containing COCs possess intrinsic anti-androgenic activity 1
  • Avoid during the first 2 years after menarche or in patients younger than 14 years unless clear clinical indication exists 1

Maintenance Therapy After Clearance

  • Continue topical retinoid (adapalene preferred) indefinitely after achieving clearance to prevent recurrence 1, 2
  • Benzoyl peroxide can be continued as maintenance to limit bacterial colonization 1, 2
  • Maintain long-term hormonal therapy (spironolactone or COC) in female patients, as discontinuation commonly leads to relapse within months 1

Essential Supportive Care

  • Use gentle, non-soap cleansers and avoid harsh scrubbing, which worsens inflammatory lesions 1
  • Apply broad-spectrum sunscreen SPF 30+ every morning—retinoids and benzoyl peroxide increase photosensitivity 1
  • After topical medications dry, apply a fragrance-free moisturizer to counteract treatment-related dryness 1
  • Avoid high-glycemic foods (white bread, sugary beverages, processed snacks) and skim milk, which have been associated with worsening acne 1

Critical Pitfalls to Avoid

  • Never use topical or oral antibiotics as monotherapy—resistance develops rapidly without concurrent benzoyl peroxide 1, 2
  • Never extend oral antibiotics beyond 3–4 months without re-evaluation, as this dramatically increases resistance risk 1, 2
  • Do not underestimate severity when scarring is present—such cases should be escalated promptly to isotretinoin regardless of lesion count 1, 4
  • Do not apply traditional tretinoin formulations with benzoyl peroxide simultaneously due to oxidation inactivating tretinoin—adapalene does not have this limitation 1
  • Never pick, squeeze, or vigorously scrub acne lesions, as these actions heighten inflammation and raise the risk of scarring 1

Special Populations

Preadolescent Children (≥9 years)

  • Benzoyl peroxide 2.5% is the primary treatment for children under 12 2
  • For predominantly comedonal acne in children ≥9 years, consider adapalene 0.1% gel 2
  • Tetracycline antibiotics are contraindicated in children under 8 years due to risk of permanent tooth discoloration 2, 5

Pregnant Patients

  • Azelaic acid is the safer alternative, classified as pregnancy category B, compared to retinoids (category C) or tazarotene (category X) 1
  • Isotretinoin, spironolactone, and tetracyclines are absolutely contraindicated in pregnancy 1, 5

References

Guideline

Acne Vulgaris Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Acne Vulgaris Management Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Treatment for Recurrent Boils and Acne Scars

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Acne Vulgaris: Diagnosis and Treatment.

American family physician, 2019

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.